MCK - McKesson Corporation

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $994.86 DETAILS

Stock News

Here's Why You Should Retain McKesson Stock in Your Portfolio for Now

McKesson's oncology growth, GLP-1 momentum and RxTS expansion support earnings strength, but pricing reform and margin pressures pose risks.

May 22, 2026 09:21 AM • zacks.com

McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know

McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

May 14, 2026 06:01 AM • zacks.com

McKesson Corporation (MCK) Presents at Bank of America Global Healthcare Conference 2026 Transcript

May 12, 2026 11:10 AM • seekingalpha.com

McKesson Q4 Earnings Call Highlights

McKesson NYSE: MCK reported a stronger fiscal fourth quarter and full fiscal 2026 performance, with executives pointing to growth across its oncology, multispecialty, pharmaceutical distribution and prescription technology businesses, while outlining plans for continued earnings growth in fiscal 2027.

May 11, 2026 11:09 AM • marketbeat.com

MCK Stock Falls Despite Q4 Earnings Beat, Sales Miss, Margins Up

McKesson beats Q4 EPS estimates as oncology and specialty distribution growth offset revenue miss and lift segment margins.

May 08, 2026 07:51 AM • zacks.com

McKesson Corporation (MCK) Q4 2026 Earnings Call Transcript

May 07, 2026 05:01 PM • seekingalpha.com

Compared to Estimates, McKesson (MCK) Q4 Earnings: A Look at Key Metrics

Although the revenue and EPS for McKesson (MCK) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

May 07, 2026 03:01 PM • zacks.com

McKesson (MCK) Surpasses Q4 Earnings Estimates

McKesson (MCK) came out with quarterly earnings of $11.69 per share, beating the Zacks Consensus Estimate of $11.56 per share. This compares to earnings of $10.12 per share a year ago.

May 07, 2026 02:55 PM • zacks.com

McKesson expects 2027 profit slightly above estimates on drug distribution strength

McKesson forecast 2027 profit slightly above Wall Street expectations after beating first-quarter profit estimates on Thursday, as the U.S. drug distributor ‌banks on strength in its oncology and specialty drug businesses.

May 07, 2026 01:50 PM • reuters.com

McKesson Reports Fiscal 2026 Fourth Quarter and Full Year Results, Provides Fiscal 2027 Guidance, and Reaffirms Long-Term Financial Growth Targets

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2026 fourth quarter financial results. Results can be accessed on McKesson's Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Thursday, May 7, at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and arch.

May 07, 2026 12:10 PM • businesswire.com

Should You Buy, Sell, or Hold McKesson Before Q4 Earnings?

MCK heads into Q4 earnings with strength in oncology, GLP-1 demand, and biopharma services, but softer medical-surgical trends may weigh.

May 07, 2026 10:35 AM • zacks.com

Countdown to McKesson (MCK) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for McKesson (MCK), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2026.

May 04, 2026 06:16 AM • zacks.com

McKesson (MCK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Apr 30, 2026 07:06 AM • zacks.com

McKesson (MCK) Falls More Steeply Than Broader Market: What Investors Need to Know

McKesson (MCK) closed the most recent trading day at $822.63, moving 1.48% from the previous trading session.

Apr 29, 2026 02:51 PM • zacks.com

Concurrent Investment Advisors LLC Raises Holdings in McKesson Corporation $MCK

Concurrent Investment Advisors LLC grew its position in McKesson Corporation (NYSE: MCK) by 62.9% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,158 shares of the company's stock after buying an additional 1,219 shares during the quarter. Concurrent Investment Advisors LLC's

Apr 29, 2026 10:10 AM • defenseworld.net

William Blair Initiates Cardinal Health at Outperform: Is the Pharma Distributor a Stealth Compounder?

William Blair launched coverage of Cardinal Health (NYSE:CAH | CAH Price Prediction) with an Outperform rating today, framing the pharma distributor as a durable franchise with specialty-led upside.

Apr 28, 2026 07:55 AM • 247wallst.com

Should Xtrackers Russell US Multifactor ETF (DEUS) Be on Your Investing Radar?

Launched on November 24, 2015, the Xtrackers Russell US Multifactor ETF (DEUS) is a passively managed exchange traded fund designed to provide a broad exposure to the Large Cap Blend segment of the US equity market.

Apr 28, 2026 03:20 AM • zacks.com

Why Congress Can't Stop Loading Up on These 3 Stocks in 2026

Somehow, members of Congress have turned relatively modest salaries into impressive investment portfolios while the rest of us grind it out in the market.

Apr 25, 2026 04:23 AM • 247wallst.com

Calamos Advisors LLC Sells 1,237 Shares of McKesson Corporation $MCK

Calamos Advisors LLC decreased its holdings in shares of McKesson Corporation (NYSE: MCK) by 3.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,545 shares of the company's stock after selling 1,237 shares during the period. Calamos Advisors LLC's holdings

Apr 24, 2026 11:58 PM • defenseworld.net

McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Apr 24, 2026 06:01 AM • zacks.com